• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

冠状动脉疾病中的钙拮抗剂

Calcium antagonists in coronary artery disease.

作者信息

Kissane B E, Lemberg L

出版信息

Heart Lung. 1982 May-Jun;11(3):280-3.

PMID:6918393
Abstract

The introduction of calcium antagonists has had a significant influence on the management of angina pectoris. Whereas, a beta blocker functions by reducing oxygen demand, the calcium antagonists increase oxygen supply and also decrease oxygen demand. The calcium ion is a vital link in excitation-contraction coupling; the regulation of intracellular calcium levels directly modulates cardiac and smooth muscle function. The three agents currently in use are verapamil, nifedipine, and diltiazem; ony the first two are available by prescription at this time. Although all three are calcium channel blocking agents, they differ in their electrophysiologic effects. Verapamil and, to a lesser extent, diltiazem slow AV nodal transmission and are thus helpful in controlling the ventricular rate in atrial fibrillation. All have a negative inotropic property which may limit their use in patients with advanced left ventricular dysfunction.

摘要

钙拮抗剂的引入对心绞痛的治疗产生了重大影响。β受体阻滞剂通过降低氧需求发挥作用,而钙拮抗剂则增加氧供应并降低氧需求。钙离子是兴奋 - 收缩偶联中的关键环节;细胞内钙水平的调节直接调节心脏和平滑肌功能。目前使用的三种药物是维拉帕米、硝苯地平和地尔硫䓬;目前只有前两种可以凭处方获得。虽然这三种都是钙通道阻滞剂,但它们的电生理效应有所不同。维拉帕米以及程度较轻的地尔硫䓬可减慢房室结传导,因此有助于控制房颤时的心室率。所有这些药物都有负性肌力作用,这可能会限制它们在晚期左心室功能不全患者中的使用。

相似文献

1
Calcium antagonists in coronary artery disease.冠状动脉疾病中的钙拮抗剂
Heart Lung. 1982 May-Jun;11(3):280-3.
2
What is preferable in unstable angina, beta-blockade or calcium-inhibition?在不稳定型心绞痛中,β受体阻滞剂或钙拮抗剂哪个更可取?
Arch Mal Coeur Vaiss. 1983 Feb;76 Spec No:199-209.
3
[Calcium inhibitors and myocardial ischemia].[钙抑制剂与心肌缺血]
Therapie. 1993 Nov-Dec;48 Spec No:671-6.
4
Calcium channel blockers for the treatment of coronary artery spasm: rationale, effects, and nursing responsibilities.用于治疗冠状动脉痉挛的钙通道阻滞剂:理论依据、作用及护理职责
Heart Lung. 1983 May;12(3):226-32.
5
Treatment of unstable angina with emphasis on calcium antagonists.不稳定型心绞痛的治疗,重点在于钙拮抗剂。
G Ital Cardiol. 1984 Nov;14(11):917-26.
6
Calcium-channel blockers and beta blockers: advantages and disadvantages of combination therapy in chronic stable angina pectoris.钙通道阻滞剂与β受体阻滞剂:慢性稳定型心绞痛联合治疗的利弊
Am Heart J. 1982 Sep;104(3):702-8. doi: 10.1016/0002-8703(82)90259-9.
7
[Comparison of the anti-angina effect of the calcium antagonists diltiazem, nifedipine and verapamil with each other and with propranolol].[钙拮抗剂地尔硫䓬、硝苯地平和维拉帕米相互之间以及与普萘洛尔的抗心绞痛效果比较]
Rev Esp Cardiol. 1987 Jul-Aug;40(4):249-55.
8
What is optimal drug therapy in angina pectoris?
Cardiovasc Clin. 1983;13(1):209-20.
9
The evolving role of calcium channel blockers in the treatment of angina pectoris: focus on felodipine.钙通道阻滞剂在心绞痛治疗中不断演变的作用:聚焦非洛地平
Can J Cardiol. 1995 Apr;11 Suppl B:14B-21B.
10
Calcium channel blockers in chronic stable angina. A review.慢性稳定型心绞痛中的钙通道阻滞剂。一篇综述。
Herz. 1982 Aug;7(4):211-20.